For years, a persistent narrative has circulated through financial circles suggesting that factor investing is effectively dead. The argument is simple and intuitive: once academic researchers discover a market anomaly and package it into a
When Katya Andresen stepped into her role as chief data, digital and AI officer at Cigna Group in 2021, she found an industry obsessed with a single question: how do we use AI? For Andresen,
Salesforce shares surged 12 percent in extended trading Wednesday after the cloud giant delivered a financial report that comfortably beat Wall Street expectations. The company reported quarterly revenue of 11.35 billion dollars, reflecting an 11
The National Science Foundation is doubling down on the future of American innovation with a fresh 90 million dollar investment aimed at launching three new Science and Technology Centers. Spanning a five year period, this
The race for the U.S. Senate in Texas just took a sharp legal turn as State Representative James Talarico's campaign moved to uncover long sealed testimonies from his opponent. On Wednesday, Talarico’s team filed a
United Parcel Service is pouring more than 2 billion dollars into a massive expansion of its international, healthcare, and supply chain operations. While these investments actually kicked off in 2024, the shipping giant only recently
For generations of investors, the dream of living off passive dividends has felt like a modern retelling of a Jane Austen novel, where one simply inherits an estate and spends their days enjoying a steady
For some cryptocurrency enthusiasts, the allure of XRP lies in its history of staggering growth. Since its debut in 2013, the digital asset has surged by an incredible 25,000 percent, fueling a persistent belief among
SpaceX is planning a monumental expansion into southern Louisiana, proposing an investment of up to 100 billion dollars to develop a massive new spaceport on Pecan Island. The project centers on roughly 125,000 acres of
Massachusetts is witnessing a strange paradox in its powerhouse biopharma sector, where a sudden dip in employment is being countered by a surge of fresh capital. A new report from MassBio reveals that the industry
